about
Metformin Prevents Nigrostriatal Dopamine Degeneration Independent of AMPK Activation in Dopamine NeuronsSelective genomic targeting by FRA-2/FOSL2 transcription factor: regulation of the Rgs4 gene is mediated by a variant activator protein 1 (AP-1) promoter sequence/CREB-binding protein (CBP) mechanismThe glycinergic system in human startle disease: a genetic screening approach.Pattern-dependent suppression of growth hormone (GH) pulsatility by ghrelin and GH-releasing peptide-6 in moderately GH-deficient rats.Manipulating sorting signals to generate co-expression of somatostatin and eGFP in the regulated secretory pathway from a monocistronic construct.Effects of the synthetic liver X receptor agonist T0901317 on the growth hormone and thyroid hormone axes in male rats.A novel GABRG2 mutation, p.R136*, in a family with GEFS+ and extended phenotypes.The orexigenic hormone acyl-ghrelin increases adult hippocampal neurogenesis and enhances pattern separation.Unacylated ghrelin promotes adipogenesis in rodent bone marrow via ghrelin O-acyl transferase and GHS-R1a activity: evidence for target cell-induced acylation.Short-term calorie restriction enhances adult hippocampal neurogenesis and remote fear memory in a Ghsr-dependent manner.Ghrelin-AMPK Signaling Mediates the Neuroprotective Effects of Calorie Restriction in Parkinson's DiseaseParadoxical leanness in the imprinting-centre deletion mouse model for Prader-Willi syndrome.Protein/DNA interaction profiling reveals novel regulators of the pineal transcriptome.Ghrelin function in human obesity and type 2 diabetes: a concise review.Ghrelin inhibits LPS-induced release of IL-6 from mouse dopaminergic neurones.Comparative analysis of the effects of ghrelin and unacylated ghrelin on luteinizing hormone secretion in male rats.NF-κB signalling is involved in immune-modulation, but not basal functioning, of the mouse suprachiasmatic circadian clock.Identification of two further splice variants of GABABR1 characterizes the conserved micro-exon 4 as a hot spot for regulated splicing in the rat brain.Ghrelin mediated neuroprotection - A possible therapy for Parkinson's disease?Reverse feeding suppresses the activity of the GH axis in rats and induces a preobesogenic state.Less is more: Caloric regulation of neurogenesis and adult brain function.Acyl ghrelin improves cognition, synaptic plasticity deficits and neuroinflammation following amyloid β (Aβ1-40) administration in mice.Hypothalamic expression of human growth hormone induces post-pubertal hypergonadotrophism in male transgenic growth retarded rats.Adiposity profile in the dwarf rat: an unusually lean model of profound growth hormone deficiency.The impact of ghrelin on the survival and efficacy of dopaminergic foetal grafts in the 6-OHDA lesioned ratCalorie restriction activates new adult born olfactory-bulb neurones in a ghrelin-dependent manner but acyl-ghrelin does not enhance subventricular zone neurogenesisGhrelin-Mediated Hippocampal Neurogenesis: Implications for Health and DiseaseAcyl-ghrelin mediated lipid retention and inflammation in obesity-related Type 2 diabetesRegulatory Architecture of the Neuronal Cacng2/Tarpγ2 Gene Promoter: Multiple Repressive Domains, a Polymorphic Regulatory Short Tandem Repeat, and Bidirectional Organization with Co-regulated lncRNAs
P50
Q28553200-D946C4CC-2558-4F6B-BE6B-67476CB0B205Q28577552-253D2201-C9AB-4C0C-B0DD-C04E6CA6A8F5Q30481905-5D2BFF87-F86A-4F8E-A3CA-DEF86395BF86Q30968614-F872A56E-7AC6-400A-93B2-D0B43D417B7FQ33208687-A407D4AF-657D-4632-B87C-44D6E65DDB3DQ33333855-DF0F496B-C9CE-48C3-80F8-6C2E4F6702BBQ34464870-15392007-513E-4210-9B01-4CBACFA9F118Q34767082-5D9443C5-DA91-469C-B517-C8E6D70B31E3Q36329584-E276C8B6-F0B3-4EDE-A608-E554E16CD9F0Q36390183-D6D0189C-BBB4-4C4C-A1C6-0671EB9B88C8Q36665912-532A83D9-B96A-49C5-A4C6-8A13933FBA04Q37428506-84985AAA-9FF3-4851-979E-00CFA309781FQ38313829-919BD841-470F-4FDA-9889-B2857F80CBB2Q39023729-2A53B9FC-4EDC-4CB7-BC63-D0540CD8829BQ39178582-259FE708-EA56-4E31-89FF-74871FCACF7FQ42490327-641431C7-D2B4-4506-B2A3-9B4C6AC70FCDQ42506289-DBA0DEAE-9B52-4D1C-A5E9-C13986072327Q46557920-D95A9B24-13BB-464C-806A-A3F5E8996247Q47895916-9C7C8260-7999-46B0-AADE-D192071DD2BDQ48161323-48356193-074A-4523-820D-54CA3462D51EQ48167921-1E5A7FBD-D4E7-4BF1-8DA9-8391EC58A3FFQ48316322-D7A3CBF7-EEEE-4727-B6FB-BB07CA785D46Q48423890-F0AA2FED-EA92-45D0-8049-E487F5E004F3Q51768748-3EE1BDC4-417A-4E8F-BEC6-4134CC8A812DQ58586898-77F26CD2-4B16-4B1A-94C0-1C6E26198EAEQ92622303-A274D1DC-007F-4E03-B2C3-A4EB824A3E02Q92843781-A5F25285-3677-423E-8FED-1DB44D8FFD54Q93139497-1BF19E5F-3B4B-4CF9-B79D-A6E0FE65D78FQ93383632-BC568CFB-88B1-4614-A504-0C0445B874F9
P50
description
British neuroscientist
@en
neurocientíficu británicu
@ast
name
Jeffrey Davies
@ca
Jeffrey Davies
@en
Jeffrey Davies
@es
Jeffrey Davies
@fr
Jeffrey S Davies
@nl
Jeffrey S Davies
@sl
type
label
Jeffrey Davies
@ca
Jeffrey Davies
@en
Jeffrey Davies
@es
Jeffrey Davies
@fr
Jeffrey S Davies
@nl
Jeffrey S Davies
@sl
altLabel
Jeff Davies
@en
Jeffrey S. Davies
@en
prefLabel
Jeffrey Davies
@ca
Jeffrey Davies
@en
Jeffrey Davies
@es
Jeffrey Davies
@fr
Jeffrey S Davies
@nl
Jeffrey S Davies
@sl
P106
P1153
56918641000
P21
P31
P3835
jeff-davies1
P496
0000-0002-4234-0033